David E. Lazar - Mar 25, 2024 Form 3 Insider Report for OPGEN INC (OPGN)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David E. Lazar
Stock symbol
OPGN
Transactions as of
Mar 25, 2024
Transactions value $
$0
Form type
3
Date filed
4/3/2024, 09:13 AM
Previous filing
Jan 31, 2024
Next filing
Apr 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OPGN Common Stock 0 Mar 25, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OPGN Series E Convertible Preferred Stock Mar 25, 2024 Common Stock 4.8M Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares of Common Stock are beneficially owned.
F2 On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings.
F3 The Series E Preferred Stock is perpetual and therefore has no expiration date.
F4 The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.